Lusman Capital Management, LLC insider trades: Autoimmune (AIMM) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lusman Capital Management, LLC reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2009 | AIMM | ↑ Buy | 78,300 | $1.22 | $96K | Indirect | Jun 30, 2009 (0d) |
| Feb 3, 2009 | AIMM | ↑ Buy | 118,000 | $0.90 | $106K | Indirect | Feb 3, 2009 (0d) |
| Dec 29, 2008 | AIMM | ↑ Buy | 41,247 | $0.87 | $36K | Indirect | Dec 31, 2008 (2d) |
| Oct 8, 2008 | AIMM | ↑ Buy | 61,100 | $1.32 | $81K | Indirect | Oct 8, 2008 (0d) |
| Oct 2, 2008 | AIMM | ↑ Buy | 86,500 | $1.36 | $118K | Indirect | Oct 3, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lusman Capital Management, LLC's insider trades
Lusman Capital Management, LLC is a 10% owner of Autoimmune (AIMM). Since Oct 2, 2008, it has reported 5 open-market purchases worth $436K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AIMM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.